| Tag | Content |
|---|
EnhancerAtlas ID | HS139-15055 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr13:49105140-49107160 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NRF1 | MA0506.1 | chr13:49106805-49106816 | CGCGCATGCGC | - | 6.02 | | NRF1 | MA0506.1 | chr13:49106806-49106817 | GCGCATGCGCA | + | 6.32 | | NRF1 | MA0506.1 | chr13:49106888-49106899 | GCGCATGCGCA | + | 6.32 | | NRF1 | MA0506.1 | chr13:49106887-49106898 | TGCGCATGCGC | - | 6.32 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09338 | chr13:49105148-49111597 | CD14 | | SE_59534 | chr13:49100931-49108617 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | CCGTACCCAT GATGTTTAAA ATTGCAACCC ACACCTGCAC TCCCAATTCC CTTTCTCTGT 60
TCTCCTTTTT CATTTTTTCA TAGCATTTGT ACTTTTCTAA CCTAATATAC AAATATGTTT 120
TTTATCATTC TTTGCTAGAA TGTAAGCTCC AGAGGGAAGG GATCTTTGTC TCTTTTGTTC 180
ATTGATGCAT CCCAAGCATC AAGGACAGGA CGTGATAGAA AATCAATTTT TGTTGAATAA 240
ATGAATGAAT CTAGGTTGAG TTCAGTAAAA AAATATCTCT GGAGTAAGTT AGTTTCCAAT 300
TTTATTTCTA CAATTAACAA ATACCTTCTG AGCTTCAATT ATGGTGGAGA TAGATTGATC 360
ATACCCTTAC AAATATATAA TATCAGATGG TGATTAAGTG CTACAAAGCC GAACCAGCAG 420
TACAAGAGTT TGGAGAGCCA GACATTTTAG GTGAGGTAGT CACCTCTCTG AAATGATGGC 480
AATTGTTTCA AGACTTAAAT AAAGTTCTGT GCCATGCAGA TTTGCGAAGA GTGGGAAAGT 540
GAGCATTGAG CATACTGGAA ATACCAAACG CAGACGCCCT GGGATGAGGG TCCGCTTGGC 600
GAGCCCAGCA AGAGCAATAA GGCCTGAGTG GTGGAAGTGG GGTATGCAAG AACGTATCAT 660
TCTTGTTGCT TTTACCTGCT GCTTAATAAC ACGCATGTAC TGTCTAGCAG GAAATAAAGA 720
GATTACGTTT CACCTAGAAT ACTCATTCTC TGAGCCTAAG TGGCTCTTCT ATTCCAGCCC 780
CCAAATATCT GTATCAGCAC ATCATATAAG ATTACAAAGC ACAGAGTAAT GACATTGTTA 840
GAAACTCTTC ACAGTAGCCC CAGGAGTCAC GAAACTGACT TAACTAAGAC CCACTGTCTA 900
GTAAGGTGTA AAACCCAGCA GGAACGCAAT ACTAGGAAGG TGCAAAGCCA GGAGGCTCAA 960
TAAACGTTAA ACAGTGTCTG GGGGAAAGAG CAACGATCCA GAGCACTGTT TGTGAACTCA 1020
ACCACTTTTA TTCAGCTCTG ACAAGGTAAG TCGCCAAGCG CGGTACAAAG TAGCTCCATG 1080
AAATGCGTTT TGTTATAGTC CTGGTCTCGA ACTGTTGCAA CATTTTATGT AATTTTTGCA 1140
AAGAACAAAA GCAAAAAGTT CATTCTAAAT TAGCCTTCCA ACTCAGTTCT TTCTCCGCCA 1200
AGACGGAGCA CTTGGAAAGT TTTCAATGTC TGAAAACCTC TATTTCCAGG GCTGAGCAGA 1260
GCACTATGTT GCGGCTTAAG ACGCTCGGCG ATTTCTTCCC ATCCCTCCGC AGTTCCAAAA 1320
CGGCTTCGCC TAACAAAGTC AAACTTTTCG CGCTATTCCT GGACATCAGG ACCAAATGTC 1380
GAAAGCATAT ACTGCCACTG AGTTAGTGAG CCGGGCCGGT GCCCGGGACC TGGGGTACTA 1440
GATTTATGGG ACGGGAGCCT AGGGGTCGAG GCCACAGAAA TGAAAACATC GGCAACATAT 1500
GCAGTGCAGC GAGTGGGTTA GGAGGGAGAA ACTTCAGGCA GGACGCTCCC TCGGGACCTG 1560
TGACGCCCCC CCAGCCACAC CAGACGTGGG AGCTTAGGAT GAGAGCGGCC TCCGAGCAGA 1620
TGATCACCCT GGAACGACGC CAAACGCGAC CCCTACCAGA GGACTCGCGC ATGCGCAGCG 1680
CAGCCTGGGC CGGCGGCCTG GGCAGGATGT AGTCGCGAGC AGCGCACCGG GCCCACGCCA 1740
GCGGAATTGC GCATGCGCAG GGCCGCCTCT GCCTGCGGCC TGGGCTGGGT GTAGCCCCGG 1800
AACCTAGCTC TTAACTCCCG CCAGCAGTTT TACGCATGCG CGACGACGCC TAGGCCTGTG 1860
GCACGGTCGC GGCTCTAGTC CCCTGGGCCC CTCAGCTGTC TCTGGCGGGG AGGTCGGGCC 1920
GCAGGGGCGG GGAGGGGTGG CCTGCCCCAG TGGTACCTGA CAGCATCCCA CGTCACGGCC 1980
GCGATCCCCC TCGGCCTCCC ACACCACTCC TCCACCCTCT 2020
|
